Exact Mass: 592.3975

nuatigenin 3-beta-D-glucopyranoside

C33H52O9 (592.3611)

Agavoside A

C33H52O9 (592.3611)

Agavoside A is found in green vegetables. Agavoside A is from the famine food Agave american From the famine food Agave americana. Agavoside A is found in green vegetables.

Santiaguine

C38H48N4O2 (592.3777)

Tuberoside

C34H56O8 (592.3975)

Tuberoside is found in mushrooms. Tuberoside is a constituent of Chinese truffles (Tuber indicum). Constituent of Chinese truffles (Tuber indicum). Tuberoside is found in mushrooms.

Avenestergenin B2

C37H52O6 (592.3764)

Avenestergenin B2 is found in cereals and cereal products. Aglycone from oat root. Aglycone from oat root. Avenestergenin B2 is found in cereals and cereal products.

PA(20:0/8:0)

C31H61O8P (592.4104)

PA(20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/8:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/20:0)

C31H61O8P (592.4104)

PA(8:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/i-18:0)

C31H61O8P (592.4104)

PA(10:0/i-18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-18:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isooctadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/i-20:0)

C31H61O8P (592.4104)

PA(8:0/i-20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoeicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/a-15:0)

C31H61O8P (592.4104)

PA(a-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/a-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/i-15:0)

C31H61O8P (592.4104)

PA(a-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/i-16:0)

C31H61O8P (592.4104)

PA(i-12:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-16:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/a-15:0)

C31H61O8P (592.4104)

PA(i-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/a-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/i-15:0)

C31H61O8P (592.4104)

PA(i-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/i-14:0)

C31H61O8P (592.4104)

PA(i-14:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-14:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-20:0/8:0)

C31H61O8P (592.4104)

PA(i-20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/8:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

1,25-Dihydroxyvitamin D3 monoglucuronide

C33H52O9 (592.3611)

Astacin

C40H48O4 (592.3552)

Di-8-ANEPPS

C36H52N2O3S (592.3698)

Dimyristoyl phosphatidic acid

C31H61O8P (592.4104)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4339)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4339)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4339)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Irumanolide II

C34H56O8 (592.3975)

Aromin

C35H60O7 (592.4339)

Bisprioterone A

C40H48O4 (592.3552)

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[fucopyranoside-3-O-acetate]

C33H52O9 (592.3611)

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[fucopyranoside-4-O-acetate]

C33H52O9 (592.3611)

Montanacin E

C35H60O7 (592.4339)

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[rhamnopyranoside-4-O-acetate]

C33H52O9 (592.3611)

7,7,8,8-Tetradehydroastaxanthin

C40H48O4 (592.3552)

7,8,7,8-Tetradehydroastaxanthin

C40H48O4 (592.3552)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

Ikshusterol 3-O-glucoside

C35H60O7 (592.4339)

(25S)-5alpha-spirost-20-ene-1beta,3alpha-diol 3-O-beta-D-glucopyranoside

C33H52O9 (592.3611)

3-(4-Hydroxybenzoyl)-1,3-Dihydroxy-14-taraxeren-28-oic acid

C37H52O6 (592.3764)

7beta-(4-hydroxybenzoyloxy)-betulinic acid

C37H52O6 (592.3764)

C33H52O9

C33H52O9 (592.3611)

3-(3,4-dihydroxyphenyl)-acrylic acid-21-(2,3-dihydroxypropoxycarbonyl)-heneicosyl ester

C34H56O8 (592.3975)

11,19-Di-Ac-Stigmasta-7,22-diene-2,3,5,6,9,11,19-heptol

C33H52O9 (592.3611)

tomentoside II

C33H52O9 (592.3611)

Symplostatin 4

C31H52N4O7 (592.3836)

3-O-beta-D-Glucopyranoside-Prazerigenin A

C33H52O9 (592.3611)

Halymecin E

C30H56O11 (592.3822)

raspacionin-A

C34H56O8 (592.3975)

3-O-alpha-L-Fucopyranoside-Ergosta-5,24(28)-diene-3,9,11,16-tetrol

C34H56O8 (592.3975)

lilioglycoside B

C33H52O9 (592.3611)

3,3-dihydroxy-2,3,2,3-tetradehydro-beta,beta-carotene-4,4-dione|astacene|Astacin|Astacin; 3.4.3.4-Tetraketo-beta-carotin|beta,beta-carotene-3,4,3,4-tetraone|Dienon-Astacin

C40H48O4 (592.3552)

floribundasaponin A|pennogenin 3-O-beta-D-glucopyranoside|pennogenin-3-O-beta-D-glucopyranoside|penogenin 3-O-beta-D-glucopyranoside

C33H52O9 (592.3611)

kryptogenin-26-O-beta-D-glucopyranoside

C33H52O9 (592.3611)

Arundifungin

C34H56O8 (592.3975)

(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside

C35H60O7 (592.4339)

(25R)-spirost-5-en-3beta,7alpha-diol-3-O-beta-D-glucopyranoside|chonglouoside SL-1

C33H52O9 (592.3611)

(4E)-1-(2,4-dihydroxyphenyl)-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-8-hydrox-5,9,13-trimethyl-6,9-oxo-tetradeca-4,12-diene-1-one|ferulaeone H

C38H56O5 (592.4128)

25-O-acetyl-3-O-[beta-L-arabinopyranosyl]cholest-5-ene-3beta,19,25-triol|junceelloside C

C34H56O8 (592.3975)

15alpha-benzoyloxy-3beta,11alpha,12-trihydroxyurs-12-en-24-al

C37H52O6 (592.3764)

3-O-beta-D-glucopyranosyl-3-epiruscogenin

C33H52O9 (592.3611)

polystanin A

C33H52O9 (592.3611)

3beta-acetoxy-27-(p-hydroxyl)benzoyloxylup-20(29)-en-28-oic acid

C37H52O6 (592.3764)

26-O-beta-D-glucopyranosylnuatigenin

C33H52O9 (592.3611)

C35H60O7

C35H60O7 (592.4339)

C37H52O6

C37H52O6 (592.3764)

C38H56O5

C38H56O5 (592.4128)

triacetyl-disidein

C37H52O6 (592.3764)

25R Delta5-spirostan-1beta,3beta-diol 1-O-beta-D-galactopyranoside

C33H52O9 (592.3611)

5alpha-spirost-25(27)-ene-1beta,3alpha-diol 3-O-beta-D-glucopyranoside

C33H52O9 (592.3611)

C34H56O8

C34H56O8 (592.3975)

suberixanthin

C42H56O2 (592.428)

O2-natafuranamine

C35H48N2O6 (592.3512)

A natural product found in Buxus natalensis.

25(R)-1beta-hydroxy-spirost-5-en-3alpha-yl O-beta-D-glucopyranoside

C33H52O9 (592.3611)

Inundoside C

C35H60O7 (592.4339)

formosalide B

C33H52O9 (592.3611)

(24S)-ergostane-1beta,3beta,5alpha,6beta-tetraol 1,3,6-triacetate

C34H56O8 (592.3975)

kryptogenin-3-O-beta-D-glucopyranoside

C33H52O9 (592.3611)

Defumarylhygrolidin

C34H56O8 (592.3975)

desacetyl-epihippurin-1

C33H52O9 (592.3611)

5alpha,8alpha-epidioxy-24(R)-methylcholesta-6,22-dien-3beta-D-glucopyranoside

C34H56O8 (592.3975)

4-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside A

C34H56O8 (592.3975)

3-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside B

C34H56O8 (592.3975)

all-trans-beta-carotenetetron-(3.4.3.4)|all-trans-beta-Carotintetron-(3.4.3.4)|astacin|Astacin, 3,4,3,4-Tetraoxo-beta-carotin

C40H48O4 (592.3552)

Arg Tyr Leu Lys

C28H48N8O6 (592.3697)

Tomatidenol-O-hexoside

C34H56O8 (592.3975)

Gallinamide A

C31H52N4O7 (592.3836)

D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides

YVKAL

C29H48N6O7 (592.3584)

Dimyristoyl phosphatidic acid

C31H61O8P (592.4104)

A phosphatidic acid in which the phosphatidyl acyl groups are both myristoyl.

Dimyristoyl-sn-glycerol 3-phosphate

C31H61O8P (592.4104)

Dimyristoyl-sn-glycerol 3-phosphate (DMPG) is a type of phospholipid that plays a crucial role in biological systems, particularly in the structure and function of cell membranes. Here's a detailed description of its biological functions: 1. **Cell Membrane Formation**: DMPG, like other phospholipids, is a key component of cell membranes. It has a hydrophilic (water-attracting) head composed of a glycerol molecule linked to a phosphate group and two hydrophobic (water-repelling) tails made up of myristic acid chains. This amphipathic nature allows DMPG to form lipid bilayers in aqueous environments, which is the basic structure of cell membranes. 2. **Membrane Fluidity**: The presence of myristic acid chains in DMPG contributes to the fluidity of cell membranes. The length and saturation of the fatty acid tails influence how tightly packed the phospholipids are in the membrane. Myristic acid, being a saturated fatty acid, tends to pack more closely, which can decrease membrane fluidity. This is important for maintaining the integrity and functionality of the membrane. 3. **Signal Transduction**: Phospholipids, including DMPG, are involved in signal transduction pathways within cells. Changes in the concentration or distribution of phospholipids can affect the activity of membrane-bound proteins, such as enzymes and receptors, which are critical for cellular signaling. 4. **Biosynthesis of Other Lipids**: DMPG serves as a precursor for the synthesis of other important lipids in the cell. For example, it can be converted into other types of phospholipids or used in the synthesis of complex lipids like sphingolipids. 5. **Role in Vesicular Transport**: In cells, DMPG is involved in the formation of transport vesicles that carry molecules within the cell and to the cell membrane. This process is essential for intracellular trafficking and secretion. 6. **Potential Involvement in Disease**: Altered levels or metabolism of phospholipids, including DMPG, have been associated with various diseases, including cardiovascular diseases and cancer. Understanding the role of DMPG in these conditions can provide insights into disease mechanisms and potential therapeutic targets.

PA(15:0/13:0)

C31H61O8P (592.4104)

PA(13:0/15:0)

C31H61O8P (592.4104)

PA(12:0/16:0)

C31H61O8P (592.4104)

PA(16:0/12:0)

C31H61O8P (592.4104)

PA(O-16:0/13:0)

C32H65O7P (592.4468)

Avenestergenin B2

C37H52O6 (592.3764)

Tuberoside

C34H56O8 (592.3975)

N-behenoyl-O-phosphocholineserine

C30H61N2O7P (592.4216)

PA 28:0

C31H61O8P (592.4104)

PA O-29:0

C32H65O7P (592.4468)

Agavosid A

C33H52O9 (592.3611)

ST 27:3;O4;Hex

C33H52O9 (592.3611)

ST 27:2;O3;GlcA

C33H52O9 (592.3611)

Astacene

C40H48O4 (592.3552)

25,26,27,28-Tetrapropoxypentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene

C40H48O4 (592.3552)

25,26,27,28-tetrahydroxy-5,11,17,23-tetrakis(1-methylethyl)calix<4>arene

C40H48O4 (592.3552)

4-tert-butyl-calix[4]arene-crown-4-complex

C40H48O4 (592.3552)

DIOCTYLMONOHEXYLPHOSPHINEOXIDE

C31H61O8P (592.4104)

Isooctyl tallate

C24H51O3Tl (592.3582)

Dimyristoylphosphatidic acid

C31H61O8P (592.4104)

Di-8-ANEPPS

C36H52N2O3S (592.3698)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

Astacin

C40H48O4 (592.3552)

1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-

C37H52O6 (592.3764)

(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid

C33H52O9 (592.3611)

(1r)-2-(Phosphonooxy)-1-[(Tridecanoyloxy)methyl]ethyl Pentadecanoate

C31H61O8P (592.4104)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] octadecanoate

C31H61O8P (592.4104)

6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5,6-tetrahydroxyoxane-2-carboperoxoic acid

C33H52O9 (592.3611)

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

C35H60O7 (592.4339)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

C35H60O7 (592.4339)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

C35H60O7 (592.4339)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

C35H60O7 (592.4339)

floribundasaponin A

C33H52O9 (592.3611)

A spirostanyl glycoside that is pennogenin attached to a beta-D-glucopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from the stem bark of Dracaena mannii, it exhibits anti-inflammatory activity.

(2R)-1-(decanoyloxy)-3-(phosphonooxy)propan-2-yl octadecanoate

C31H61O8P (592.4104)

di-8-ANEPPS dye

C36H52N2O3S (592.3698)

CID 53394716

C33H60N4O3S (592.4386)

2-[[(2R)-2-butanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

NAGlySer 10:0/18:3

C33H56N2O7 (592.4087)

NAGlySer 12:0/16:3

C33H56N2O7 (592.4087)

NAGlySer 18:3/10:0

C33H56N2O7 (592.4087)

NAGlySer 16:3/12:0

C33H56N2O7 (592.4087)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate

C30H57O9P (592.374)

Mgdg O-22:6_2:0

C33H52O9 (592.3611)

PE-Cer 12:2;2O/18:5

C32H53N2O6P (592.3641)

PE-Cer 14:3;2O/16:4

C32H53N2O6P (592.3641)

PE-Cer 16:0;2O/12:1;O

C30H61N2O7P (592.4216)

PE-Cer 12:0;2O/16:1;O

C30H61N2O7P (592.4216)

PE-Cer 16:1;2O/12:0;O

C30H61N2O7P (592.4216)

PE-Cer 14:1;2O/14:0;O

C30H61N2O7P (592.4216)

PE-Cer 13:1;2O/15:0;O

C30H61N2O7P (592.4216)

PE-Cer 14:0;2O/14:1;O

C30H61N2O7P (592.4216)

PE-Cer 15:0;2O/13:1;O

C30H61N2O7P (592.4216)

PE-Cer 13:0;2O/15:1;O

C30H61N2O7P (592.4216)

PE-Cer 12:1;2O/16:0;O

C30H61N2O7P (592.4216)

PE-Cer 15:1;2O/13:0;O

C30H61N2O7P (592.4216)

PMeOH 13:0_14:0

C31H61O8P (592.4104)

PEtOH 12:0_14:0

C31H61O8P (592.4104)

PEtOH 13:0_13:0

C31H61O8P (592.4104)

PMeOH 12:0_15:0

C31H61O8P (592.4104)

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C31H61O8P (592.4104)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C31H61O8P (592.4104)

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C31H61O8P (592.4104)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) pentacosanoate

C31H61O8P (592.4104)

(1-Acetyloxy-3-phosphonooxypropan-2-yl) hexacosanoate

C31H61O8P (592.4104)

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C31H61O8P (592.4104)

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C31H61O8P (592.4104)

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C31H61O8P (592.4104)

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate

C31H61O8P (592.4104)

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) pentadecanoate

C31H61O8P (592.4104)

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) heptadecanoate

C31H61O8P (592.4104)

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C31H61O8P (592.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] heptadecanoate

C31H61O8P (592.4104)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[3-[2,3-bis[[(6E,9E)-dodeca-6,9-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] heptadecanoate

C31H61O8P (592.4104)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C38H56O5 (592.4128)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C38H56O5 (592.4128)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

2-[hydroxy-[2-nonanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-butanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

[3-[3-butanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213)

2-[hydroxy-[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-acetyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

2-[hydroxy-[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

[1-carboxy-3-[3-hexanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213)

[3-[3-acetyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213)

2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

2-[[2-heptanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-heptanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO8P+ (592.3978)

2-[carboxy-[2-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C34H58NO7+ (592.4213)

2-[hydroxy-[3-octoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-butanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-nonoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[2-octanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-acetyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-decoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-decanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-[(Z)-heptadec-9-enoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

agavoside A

C33H52O9 (592.3611)

A steroid saponin that consists of (25R)-5alpha-spirostan-3beta-ol substituted by an oxo group at position 12 and a beta-D-galactopyranosyl moiety at position 3 via a glycosidic linkage.

(-)-Santiaguine

C38H48N4O2 (592.3777)

Dimyristoyl-sn-glycerol 3-phosphate

C31H61O8P (592.4104)

1beta-hydroxymaprounic acid 3-p-hydroxybenzoate

C37H52O6 (592.3764)

A pentacyclic triterpenoid that is the benzoate ester obtained by the condensation of the 3-hydroxy group of 1beta-hydroxymaprounic acid with p-hydroxybenzoic acid. Isolated from Maprounea africana, it exhibits inhibitory activity against HIV-1 reverse transcriptase.

1-dodecanoyl-2-hexadecanoyl-glycero-3-phosphate

C31H61O8P (592.4104)

1-decanoyl-2-stearoyl-sn-phosphatidic acid

C31H61O8P (592.4104)

A 1,2-diacyl-sn-glycerol 3-phosphate (sn-phosphatidic acid) in which the acyl groups at positions 1 and 2 are specified as decanoyl and stearoyl respectively.

calcitriol 25-O-(beta-D-glucuronide)

C33H52O9 (592.3611)

A steroid glucosiduronic acid that is calcitriol in which the hydroxy hydrogen at position 25 has been replaced by a beta-D-glucuronyl residue.

1,2-ditetradecanoyl-sn-glycerol-3-phosphate

C31H61O8P (592.4104)

A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as tetradecanoyl (myristoyl).

MGDG O-22:0;O

C31H60O10 (592.4186)

MGDG O-24:6

C33H52O9 (592.3611)

MGMG 24:6

C33H52O9 (592.3611)

LPA 29:0

C32H65O7P (592.4468)

PA O-14:0/15:0

C32H65O7P (592.4468)

PA O-16:0/13:0

C32H65O7P (592.4468)

PA O-18:0/11:0

C32H65O7P (592.4468)

PA O-20:0/7:2;O2

C30H57O9P (592.374)

PA O-20:0/8:1;O

C31H61O8P (592.4104)

PA O-27:2;O2

C30H57O9P (592.374)

PA O-28:1;O

C31H61O8P (592.4104)

PA P-18:0/9:1;O2

C30H57O9P (592.374)

PA 18:0/9:1;O

C30H57O9P (592.374)

PA 22:0/5:1;O

C30H57O9P (592.374)

PA 27:1;O

C30H57O9P (592.374)

PA 10:0_18:0

C31H61O8P (592.4104)

PA 11:0_17:0

C31H61O8P (592.4104)

PA 12:0_16:0

C31H61O8P (592.4104)

PA 13:0_15:0

C31H61O8P (592.4104)

PA 14:0/14:0

C31H61O8P (592.4104)

PA 24:0/4:0

C31H61O8P (592.4104)

PA 26:0/2:0

C31H61O8P (592.4104)

LPG 24:2

C30H57O9P (592.374)

PG O-20:1/4:1

C30H57O9P (592.374)

PG O-20:2/4:0

C30H57O9P (592.374)

PG O-22:2/2:0

C30H57O9P (592.374)

PG O-24:2

C30H57O9P (592.374)

PG P-20:0/4:1

C30H57O9P (592.374)

PG P-20:0/4:1 or PG O-20:1/4:1

C30H57O9P (592.374)

PG P-20:1/4:0

C30H57O9P (592.374)

PG P-20:1/4:0 or PG O-20:2/4:0

C30H57O9P (592.374)

PG P-22:1/2:0

C30H57O9P (592.374)

PG P-22:1/2:0 or PG O-22:2/2:0

C30H57O9P (592.374)

PG P-24:1

C30H57O9P (592.374)

PG P-24:1 or PG O-24:2

C30H57O9P (592.374)

PI O-10:0/10:0

C26H57O12P (592.3587)

LPEth 27:0

C32H65O7P (592.4468)

LPEth 28:7

C33H53O7P (592.3529)

LPM 28:0

C32H65O7P (592.4468)

LPM 29:7

C33H53O7P (592.3529)

PEth 25:1;O

C30H57O9P (592.374)

PEth 26:0

C31H61O8P (592.4104)

PM 26:1;O

C30H57O9P (592.374)

PM 27:0

C31H61O8P (592.4104)

CerPE 14:1;O2/14:0;O

C30H61N2O7P (592.4216)

CerPE 15:1;O2/13:0;O

C30H61N2O7P (592.4216)

CerPE 16:1;O2/12:0;O

C30H61N2O7P (592.4216)

CerPE 17:1;O2/11:0;O

C30H61N2O7P (592.4216)

CerPE 18:1;O2/10:0;O

C30H61N2O7P (592.4216)

CerPE 28:1;O2;O

C30H61N2O7P (592.4216)

SM 14:1;O2/11:0;O

C30H61N2O7P (592.4216)

SM 15:1;O2/10:0;O

C30H61N2O7P (592.4216)

SM 25:1;O2;O

C30H61N2O7P (592.4216)

ST 28:1;O2;GlcA

C34H56O8 (592.3975)

ST 29:0;O;GlcA

C35H60O7 (592.4339)

ST 29:1;O2;Hex

C35H60O7 (592.4339)

LCL521

C31H52N4O7 (592.3836)

LCL521 is an acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the lysosomal acid sphingomyelinase (ASMase)[1].

PA(14:0_14:0)

C31H61O8P (592.4104)

-

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

2-hydroxy-4-[12-hydroxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-4-yl]-3-isopropyl-7-methyl-8-(4-methylpent-3-en-1-yl)-4h-naphthalen-1-one

C40H48O4 (592.3552)

2-{[1-(5,6-dimethylhept-3-en-2-yl)-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H56O8 (592.3975)

6-{2-[7-(acetyloxy)-3-hydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-2,2,5a,7-tetramethyl-3-oxo-hexahydro-1-benzoxepin-7-yl acetate

C34H56O8 (592.3975)

(2r,3r,4s,5r)-2-{[(2z,6r)-6-[(1r,3r,5s,5as,7s,9ar,9br,11ar)-3,5,7-trihydroxy-9a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-3-isopropylhept-2-en-1-yl]oxy}oxane-3,4,5-triol

C34H56O8 (592.3975)

(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

3-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C33H52O9 (592.3611)

n-[(1r,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

(3s,5as,6s,7s,9as)-3-(acetyloxy)-6-{2-[(1s,2r,3r,6s,9r)-9-hydroxy-2,3,8,8-tetramethyl-7,12-dioxatricyclo[7.2.1.0¹,⁶]dodecan-2-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O8 (592.3975)

(1s,5r,6r,7r,8s,9z,11s,15e,17r)-1,7,11-trihydroxy-5-[(2s,4s,5r,6r)-5-hydroxy-4,6-dimethyl-7-oxononan-2-yl]-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one

C34H56O8 (592.3975)

1,7,11-trihydroxy-5-(5-hydroxy-4,6-dimethyl-7-oxononan-2-yl)-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one

C34H56O8 (592.3975)

2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

methyl (3s)-3-[(3s,3as,5ar,6s,7s,9r,9ar)-3-[(3s,5r,6s)-5,6-dihydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-9-hydroxy-3a,6,9a-trimethyl-7-(prop-1-en-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]-3-(acetyloxy)propanoate

C33H52O9 (592.3611)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H56O8 (592.3975)

2-(hydroxymethyl)-6-{5,9',13'-trimethyl-7'-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy}oxane-3,4,5-triol

C33H52O9 (592.3611)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

4-{[1-hydroxy-3a,6,6,9a,11a-pentamethyl-1-(5,6,7-trihydroxy-6-methylheptan-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-oxobutanoic acid

C34H56O8 (592.3975)

2-{[2-(dimethylamino)-3-methylpentanoyl]oxy}-n-(1-{[5-(3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-2-yl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-4-methylpentanimidic acid

C31H52N4O7 (592.3836)

6-hydroxy-3-[(9e,11e,13e,15e)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H48O4 (592.3552)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

methyl (3s)-3-[(3s,3as,5ar,6s,7s,9r,9ar)-3-[(3r,5r,6s)-5-(acetyloxy)-6-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-9-hydroxy-3a,6,9a-trimethyl-7-(prop-1-en-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]-3-hydroxypropanoate

C33H52O9 (592.3611)

2-[(3s,14s,15s)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C31H52N4O7 (592.3836)

(2s,6r)-2-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-2-oxo-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one

C33H52O9 (592.3611)

[(1r,3ar,5r,5ar,7r,8r,9ar,9br,10r,11ar)-10-(acetyloxy)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-5,5a,7,8,9b-pentahydroxy-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate

C33H52O9 (592.3611)

(1s,2s,4s,7s,8r,9s,12s,13r)-6-hydroxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-17-en-16-one

C33H52O9 (592.3611)

(5r)-3-{[(2s,5s)-5-[(8s)-8-hydroxy-8-[(2s,5s)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13's,14'r,16's,18's)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

[10-(acetyloxy)-1-(5-ethyl-6-methylhept-3-en-2-yl)-5,5a,7,8,9b-pentahydroxy-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate

C33H52O9 (592.3611)

n-[(1s,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s,21r)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C33H52O9 (592.3611)

(1r,3as,3bs,7s,9ar,9bs,11as)-1-[(2s,6r)-7-hydroxy-6-methyl-3-oxoheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

C33H52O9 (592.3611)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl 3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,8's,9's,12's,13's,14'r,16's,18's)-5,9',13'-trimethyl-7'-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-8'-oloxy}oxane-3,4,5-triol

C33H52O9 (592.3611)

(5s)-3-{[(2r,6s)-6-[(7r)-7-hydroxy-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3a-yl 3,4-dimethoxybenzoate

C38H56O5 (592.4128)

2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H56O8 (592.3975)

6-[9a-(hydroxymethyl)-11a-methyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-2-yl acetate

C34H56O8 (592.3975)

5,7',9',13'-tetramethyl-16'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C33H52O9 (592.3611)

n-[16-(acetyloxy)-10-[1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

(6r)-6-[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-7-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-2-yl acetate

C34H56O8 (592.3975)

3,5,5-trimethyl-4-[(9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3,4-dioxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H48O4 (592.3552)

bis(eburnamine)

C38H48N4O2 (592.3777)

(2s,3s,4ar,5r,8as)-3-{[(2r,3s,4r,5r,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

5-methoxy-2-[18-(4-methoxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-1,3,3-trimethylcyclohex-1-ene

C42H56O2 (592.428)

16-ethyl-9-{16-ethyl-7-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium-6-yl}-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

[C38H48N4O2]2+ (592.3777)

2-{[1-(5-ethyl-6-methylheptan-2-yl)-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

3-{[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C33H52O9 (592.3611)

(6s)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H48O4 (592.3552)

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4r,5r,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

(6r)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H48O4 (592.3552)

2-{[5-(5,6-dimethylhept-3-en-2-yl)-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadecan-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H56O8 (592.3975)

(2s,3s,4as,5r,8as)-3-{[(2s,3r,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

(2s)-2-{[(2s)-2-{[(2s,3s)-2-(dimethylamino)-3-methylpentanoyl]oxy}-1-hydroxy-4-methylpentylidene]amino}-n-[(2s,3e)-5-[(2s)-3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl]-5-oxopent-3-en-2-yl]-4-methylpentanimidic acid

C31H52N4O7 (592.3836)

1-(2,4-diphenyl-3-{3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine-1-carbonyl}cyclobutanecarbonyl)-3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine

C38H48N4O2 (592.3777)

5-{[(3r,5r)-5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl]oxy}-3,9-dihydroxydecanoic acid

C30H56O11 (592.3822)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,5r,6r,9r,10r,13s,15r)-5-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadecan-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H56O8 (592.3975)

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3,9-dihydroxydecanoic acid

C30H56O11 (592.3822)

(3r,5as,6r,7r,9as)-3-(acetyloxy)-6-{2-[(1s,2s,3s,6s,9s)-9-hydroxy-2,3,8,8-tetramethyl-7,12-dioxatricyclo[7.2.1.0¹,⁶]dodecan-2-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O8 (592.3975)

(5r)-3-{[(2s,6r)-6-[(7r)-7-hydroxy-7-[(2r,5s)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(2s,3s,4r,5r)-2-{[(1r,3as,3bs,7s,9as,9bs,11ar)-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,5-dihydroxyoxan-4-yl acetate

C34H56O8 (592.3975)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxane-3,4,5-triol

C33H52O9 (592.3611)

methyl 3-{3-[5-(acetyloxy)-6-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-9-hydroxy-3a,6,9a-trimethyl-7-(prop-1-en-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl}-3-hydroxypropanoate

C33H52O9 (592.3611)

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8's,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

[(1s,2s,4ar,4bs,6as,11as,11br,13ar)-2,10-dihydroxy-1,4a,6a,11b-tetramethyl-1-{2-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]ethyl}-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthren-7-yl](hydroxy)acetic acid

C38H56O5 (592.4128)

4,5-dihydroxy-6-{[1-(6-hydroxy-6-methylheptan-2-yl)-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxan-3-yl acetate

C34H56O8 (592.3975)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

3-(acetyloxy)-6-(2-{9-hydroxy-2,3,8,8-tetramethyl-7,12-dioxatricyclo[7.2.1.0¹,⁶]dodecan-2-yl}ethyl)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O8 (592.3975)

8-hydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-15-yl acetate

C33H52O9 (592.3611)

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1s)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(2s,3s,4ar,5r,8as)-3-{[(2r,3s,4s,5s,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

2-{7-hydroxy-9a,11a-dimethyl-2-oxo-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one

C33H52O9 (592.3611)

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

3,5-dihydroxy-2-{[1-(6-hydroxy-6-methylheptan-2-yl)-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxan-4-yl acetate

C34H56O8 (592.3975)

2-(hydroxymethyl)-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy}oxane-3,4,5-triol

C33H52O9 (592.3611)

(5as,6s,7s,9as)-6-{2-[(3s,5as,6s,7r,9as)-7-(acetyloxy)-3-hydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-2,2,5a,7-tetramethyl-3-oxo-hexahydro-1-benzoxepin-7-yl acetate

C34H56O8 (592.3975)

(2s,3s,4ar,5r,8as)-3-{[(2r,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

(5s)-3-{[(2s,6r)-6-[(7r)-7-hydroxy-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

hydroxy[(1r,2s,5s,13s,14r,17r,18s,21s,26s,28s)-10-hydroxy-1,5,14,18,22,22,26-heptamethyl-27-oxaheptacyclo[15.13.0.0²,¹⁴.0⁵,¹³.0⁶,¹¹.0¹⁸,²⁸.0²¹,²⁶]triaconta-6,8,10-trien-7-yl]acetic acid

C38H56O5 (592.4128)

1-(7-hydroxy-6-methyl-3-oxoheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

C33H52O9 (592.3611)

(4s)-2-hydroxy-4-[(3r,4s)-12-hydroxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-4-yl]-3-isopropyl-7-methyl-8-(4-methylpent-3-en-1-yl)-4h-naphthalen-1-one

C40H48O4 (592.3552)

1-(5-ethyl-6-methylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3a-yl 3,4-dimethoxybenzoate

C38H56O5 (592.4128)

2-[5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C31H52N4O7 (592.3836)

(1s,4r,5r,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-hydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-15-yl acetate

C33H52O9 (592.3611)

3-[(5-{8-hydroxy-8-[5-(1-hydroxytridecyl)oxolan-2-yl]-2-oxooctyl}oxolan-2-yl)methyl]-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4s,5s,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O8 (592.3975)

3-[(6-{7-hydroxy-7-[5-(1-hydroxytridecyl)oxolan-2-yl]-2-oxoheptyl}oxan-2-yl)methyl]-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(2r)-2-(pentadecanoyloxy)-3-(tridecanoyloxy)propoxyphosphonic acid

C31H61O8P (592.4104)

(5s)-5-methoxy-2-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-methoxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-1,3,3-trimethylcyclohex-1-ene

C42H56O2 (592.428)

2-(hydroxymethyl)-6-[5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O9 (592.3611)